IRIS Accounts Production v24.2.0.383 12222183 Board of Directors 1.4.23 31.3.24 31.3.24 false true false false false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh122221832023-03-31122221832024-03-31122221832023-04-012024-03-31122221832022-03-31122221832022-04-012023-03-31122221832023-03-3112222183ns15:EnglandWales2023-04-012024-03-3112222183ns14:PoundSterling2023-04-012024-03-3112222183ns10:Director12023-04-012024-03-3112222183ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3112222183ns10:Micro-entities2023-04-012024-03-3112222183ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3112222183ns10:FullAccounts2023-04-012024-03-3112222183ns5:CurrentFinancialInstruments2024-03-3112222183ns5:CurrentFinancialInstruments2023-03-3112222183ns5:Non-currentFinancialInstruments2024-03-3112222183ns5:Non-currentFinancialInstruments2023-03-3112222183ns10:RegisteredOffice2023-04-012024-03-31122221831ns10:Director12023-03-31122221831ns10:Director12022-03-31122221831ns10:Director12023-04-012024-03-31122221831ns10:Director12022-04-012023-03-31122221831ns10:Director12024-03-31122221831ns10:Director12023-03-3112222183ns10:Director22023-04-012024-03-3112222183ns10:Director222023-03-3112222183ns10:Director222022-03-3112222183ns10:Director222023-04-012024-03-3112222183ns10:Director222022-04-012023-03-3112222183ns10:Director222024-03-3112222183ns10:Director222023-03-31
REGISTERED NUMBER: 12222183 (England and Wales)







UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024

FOR

BLUEBERRY MEDICAL LIMITED

BLUEBERRY MEDICAL LIMITED (REGISTERED NUMBER: 12222183)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024




Page

Balance Sheet 1


BLUEBERRY MEDICAL LIMITED (REGISTERED NUMBER: 12222183)

BALANCE SHEET
31 MARCH 2024

2024 2023
£    £    £    £   
FIXED ASSETS 15,331 16,678

CURRENT ASSETS 247,630 192,244

CREDITORS
Amounts falling due within one year (30,963 ) (28,100 )
NET CURRENT ASSETS 216,667 164,144
TOTAL ASSETS LESS CURRENT
LIABILITIES

231,998

180,822

CREDITORS
Amounts falling due after more than
one year

11,013

12,646
NET ASSETS 220,985 168,176

CAPITAL AND RESERVES 220,985 168,176

NOTES TO THE FINANCIAL STATEMENTS

1. STATUTORY INFORMATION

Blueberry Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 12222183

Registered office: Rex Buildings
Alderley Road
Wilmslow
Cheshire
SK9 1HY

2. AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 2 (2023 - 2 ) .

BLUEBERRY MEDICAL LIMITED (REGISTERED NUMBER: 12222183)

BALANCE SHEET - continued
31 MARCH 2024

NOTES TO THE FINANCIAL STATEMENTS

3. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 March 2024 and 31 March 2023:

2024 2023
£    £   
Dr R Wong
Balance outstanding at start of year (4,288 ) (2,095 )
Amounts advanced 1,783 60
Amounts repaid (1,051 ) (2,253 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (3,556 ) (4,288 )

Mrs B Wong
Balance outstanding at start of year 80,233 (25,000 )
Amounts advanced 1,840 105,233
Amounts repaid (1,840 ) -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 80,233 80,233

The loan was advanced to the director last year. This loan included interest at the official HMRC rate and remains outstanding.



BLUEBERRY MEDICAL LIMITED (REGISTERED NUMBER: 12222183)

BALANCE SHEET - continued
31 MARCH 2024


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 13 June 2024 and were signed on its behalf by:





Dr R Wong - Director